4.6 Article

The USP19 Deubiquitinase Regulates the Stability of c-IAP1 and c-IAP2

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 286, 期 41, 页码 35380-35387

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.282020

关键词

-

资金

  1. National Institutes of Health [CA108872, GM060911]
  2. Leukemia & Lymphoma Society

向作者/读者索取更多资源

The inhibitors of apoptosis (IAPs) are critical regulators of apoptosis and other fundamental cellular processes. Many IAPs are RING domain-containing ubiquitin E3 ligases that control the stability of their interacting proteins. However, how IAP stability is regulated remains unclear. Here we report that USP19, a deubiquitinating enzyme, interacts with cellular IAP 1 (c-IAP1) and c-IAP2. Knockdown of USP19 decreases levels of both c-IAPs, whereas overexpression of USP19 results in a marked increase in c-IAP levels. USP19 effectively removes ubiquitin from c-IAPs in vitro, but it stabilizes c-IAPs in vivo mainly through deubiquitinase-independent mechanisms. The deubiquitinase activity is involved in the stabilization of USP19 itself, which is facilitated by USP19 self-association. Functionally, knockdown of USP19 enhances TNF alpha-induced caspase activation and apoptosis in a c-IAP1 and 2-dependent manner. These results suggest that the self-ubiquitin ligase activity of c-IAPs is inhibited by USP19 and implicate deubiquitinating ;enzymes in the regulation of IAP stability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Hematology

Incidental but rapidly progressing T-cell prolymphocytic leukemia with t( X;14)(q28;q11) involving parotid lymphoepithelial cysts: A diagnostic pitfall

Anindita Ghosh, Lei Chen, Amer Wahed, Wei Wang, Karan Saluja, Andy N. D. Nguyen, Shimin Hu, Zhihong Hu

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2022)

Letter Oncology

Well-differentiated systemic mastocytosis with associated myeloid sarcoma and myelodysplastic syndrome: Diagnostic challenges of an underrecognized entity

Siba El Hussein, Shimin Hu, Hong Fang, Sofia Garces, Tariq Muzzafar, Sa A. Wang, L. Jeffrey Medeiros, Carlos Bueso-Ramos, FatimaZahra Jelloul

LEUKEMIA & LYMPHOMA (2022)

Review Pathology

Composite Classic Hodgkin Lymphoma and Follicular Lymphoma A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature

Yuhua Huang, Shimin Hu, Daniel P. Larson, Min Shi, Rong He, Bhavana J. Dave, Timothy C. Greiner, Kai Fu, Ellen D. McPhail, Rhett P. Ketterling, L. Jeffrey Medeiros, Ji Yuan

Summary: Composite classic Hodgkin lymphoma and follicular lymphoma (CHLFL) is a rare entity that predominantly occurs in older adults, involves lymph nodes, and most commonly presents as de novo cases. In a small number of cases assessed, the CHL and FL components are usually clonally related.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Article Hematology

3 ' CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant

Guilin Tang, Ying Zou, Sa A. Wang, Gautam Borthakur, Gokce Toruner, Shimin Hu, Shaoying Li, Jie Xu, L. Jeffrey Medeiros, Zhenya Tang

Summary: Fluorescence in situ hybridization (FISH) analysis is widely used for detecting CBFB rearrangement (CBFBr) in acute myeloid leukemia (AML). However, the clinical importance of 3'CBFB deletion (3'CBFBdel) associated with CBFBr is largely unknown. This study identified AML patients with 3'CBFBdel and found that most of them had CBFB::MYH11 fusion. These patients showed similar pathological features to AML with inv(16), but had different mutation profiles and a higher risk of relapse requiring hematopoietic stem cell transplant.

ANNALS OF HEMATOLOGY (2022)

Article Cell Biology

EBV+ high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study

Hui Liu, Zijun Y. Xu-Monette, Guilin Tang, Wei Wang, Young Kim, Ji Yuan, Yu Li, Weina Chen, Yanping Li, George Y. Fedoriw, Feng Zhu, Xiaosheng Fang, Catherine Luedke, L. Jeffrey Medeiros, Ken H. Young, Shimin Hu

Summary: This study identified 16 cases of EBV+ DHL/THL, with half presenting high-grade/Burkitt-like morphology and the other half diffuse large B cell lymphoma morphology. Using Hans' algorithm, 13 cases were classified as germinal centre B cell and 3 as non-GCB. Most cases showed EBV latency Type I, with a median of 80% positive cells for EBV-encoded small RNAs.

HISTOPATHOLOGY (2022)

Review Pathology

The many faces of plasma cell neoplasms: morphological and immunophenotypical variants of the great imitator

Siba El Hussein, L. Jeffrey Medeiros, Shimin Hu, Pei Lin, Wei Wang

Summary: This review provides a concise yet comprehensive summary of the morphological and immunophenotypical variants of plasma cell neoplasms, emphasizing the potential diagnostic pitfalls.

PATHOLOGY (2022)

Letter Hematology

Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survival

Xiaoqiong Wang, Guilin Tang, Zhihong Hu, Hong Fang, Wei Wang, Zhenya Tang, Gokce A. Toruner, Ting Zhou, Courtney D. DiNardo, Guillermo Garcia-Manero, Srdan Verstovsek, Carlos E. Bueso-Ramos, L. Jeffrey Medeiros, Shimin Hu

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Pathology

Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations

Mehrnoosh Tashakori, Joseph D. Khoury, Mark J. Routbort, Keyur P. Patel, Sa A. Wang, Chi Young Ok, Siba El-Hussein, Rashmi Kanagal-Shamanna, Rajyalakshmi Luthra, Shimin Hu, Pei Lin, Naveen Pemmaraju, Prithviraj Bose, Srdan Verstovsek, Carlos E. Bueso-Ramos, L. Jeffrey Medeiros, Sanam Loghavi

Summary: This study evaluated the clinicopathologic spectrum of myeloid neoplasms with concurrent MPN-driver mutations and SRSF2 mutations. The results suggest that patients with these mutations exhibit clinical and morphologic features similar to classic MPNs, often with dysplasia and monocytosis.

MODERN PATHOLOGY (2022)

Article Pathology

Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms

Hong Fang, Joseph D. Khoury, Carlos A. Torres-Cabala, Siok Bian Ng, Jie Xu, Siba El Hussein, Shimin Hu, Francisco Vega, Shaoying Li, Zhenya Tang, Guilin Tang, L. Jeffrey Medeiros, Wei Wang

Summary: In this study, the expression of BCL11B in various T-cell neoplasms was investigated through immunohistochemical analysis. The results showed that BCL11B was positively expressed in certain types of T-cell lymphomas, but the expression was weaker in reactive cutaneous conditions. BCL11B was negative in NK-cell neoplasms and B-cell lymphomas.

PATHOLOGY (2022)

Article Oncology

Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm

Wei Wang, Jie Xu, Joseph D. Khoury, Naveen Pemmaraju, Hong Fang, Roberto N. Miranda, C. Cameron Yin, Siba El Hussein, Fuli Jia, Zhenya Tang, Shimin Hu, Marina Konopleva, L. Jeffrey Medeiros, Sa A. Wang

Summary: This study investigated the immunophenotypic and molecular profiles of pDC-AML and BPDCN and found that they have different phenotypes and mutation profiles, indicating that they are two distinct entities.

CANCERS (2022)

Article Medical Laboratory Technology

Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors

Hong Fang, Sa A. Wang, M. James You, Shimin Hu, Roberto N. Miranda, Zhenya Tang, Pei Lin, Jeffrey L. Jorgensen, Jie Xu, Beenu Thakral, Ellen J. Schlette, Siba El Hussein, Carlos Bueso-Ramos, L. Jeffrey Medeiros, Wei Wang

Summary: The immunophenotype of pure erythroid leukemia (PEL) differs significantly from reactive conditions. PEL is characterized by positive expression of CD36 and CD71, dimmer expression of CD45, variable expression of CD117 and CD235a, decreased or negative expression of CD38, aberrant expression of CD7 and CD13, abnormal expression of CD4 and absence of CD34.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2022)

Letter Oncology

HHV8-Negative Effusion-Based lymphoma in a patient with recurrent HCV hepatitis status post liver transplantation

Wei Wang, Brandon T. Gehris, Brenda Mai, Lei Chen, Shimin Hu, M. James You, Zhihong Hu

LEUKEMIA & LYMPHOMA (2022)

Letter Hematology

Clonally related composite chronic lymphocytic leukaemia and mantle cell lymphoma

Qianze Dong, Yang Wang, Yan Xiu, Hany Sakr, Bettina Burnworth, Dongbin Xu, Timothy O'Brien, Juanita Burke, Shimin Hu, Gang Zeng, Chen Zhao

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Oncology

Clinical impact of 5'MYC or 3'MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas

Guilin Tang, Shaoying Li, Gokce A. Toruner, Preetesh Jain, Zhenya Tang, Shimin Hu, Jie Xu, Joanne Cheng, Melissa Robinson, Francisco Vega, L. Jeffrey Medeiros

Summary: FISH analysis using MYC break-apart probes is a commonly used technique to assess for MYC rearrangement. However, atypical signal patterns can occur, such as gain or loss of 5'MYC or 3'MYC. This study evaluated patients with aggressive B-cell lymphomas who exhibited atypical FISH signal patterns and found that 5'MYC gain is associated with MYC expression and a poorer prognosis, while 3'MYC deletions are not associated with MYC expression or a poorer prognosis and may be unrelated to MYC-R.

CANCER GENETICS (2023)

Article Oncology

Targetable vulnerability of deregulated FOXM1/PLK1 signaling axis in diffuse large B cell lymphoma

Fang Yu, Hua He, Loretta J. Nastoupil, Zijun Y. Xu-Monette, Ky Pham, Yong Liang, Guang Chen, Nathan H. Fowler, C. Cameron Yin, Dongfeng Tan, Yaling Yang, Shimin Hu, Ken H. Young, Lan Pham, M. James You

Summary: FOXM1 is a transcription factor that plays important roles in cell cycle regulation, cell proliferation, and differentiation. Its overexpression is associated with poor prognosis in diffuse large B cell lymphoma (DLBCL). FOXM1 forms a functional axis with PLK1, which is involved in the regulation of cell cycle and DNA damage/repair pathways.

AMERICAN JOURNAL OF CANCER RESEARCH (2022)

暂无数据